CRL Charles River Laboratories International, Inc.

NYSE
$286.83

Charles River Laboratories International, Inc. (CRL) is expected to report earnings on November 6, 2026, before the market open. The consensus earnings estimate is $2.97 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +7.0% since its last earnings release on August 5, 2026.

Charles River Laboratories International Beat Consensus Estimates, Raises Guidance
Wednesday, August 5, 2026 · 7:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 6
Friday · 7:00 AM ET
Earnings Whisper
-
vs $2.97
Rev est $955.44M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $283.35

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Charles River Laboratories International, Inc.

Charles River Laboratories International Inc provides research models and services required to enable in vivo drug discovery and development.

Sector

Healthcare

Industry

Research Services

Held By 5 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.